Scorpius Holdings Inc. (SCPX): מקדם מחיר להכנסות

לוגו תאגידי של חברת NightHawk Biosciences (SCPX)

Scorpius Holdings, Inc. (SCPX) leverages a vertically integrated CDMO platform for the rapid launch of biologics as the foundation of its growth. The price/sales ratio dynamics confirm this trajectory, with the 0.00 indicator determining the metric's magnitude. Business scalability relies on test automation and personnel qualifications. The stability of market positions is ensured by the expansion of the bioreactor fleet, which creates a significant barrier to entry for new players.

SCPX NightHawk Biosciences: יחס מחיר להכנסות בטווח 21.02.2024 - 26.04.2025

פילוחי מדדים ואנליטיקה של חברת NightHawk Biosciences (SCPX)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח כללי של החברה:SCPX, NightHawk Biosciences
מוצרים מוגמרים של Scorpius Holdings Inc.

The stability of Scorpius Holdings, Inc. (SCPX) depends on its ability to compete with global CDMO behemoths in the race for pharmaceutical contracts. By analyzing the P/S multiple, an investor assesses market capitalization relative to annual revenue, which allows for the determination of the asset's overvaluation and the identification of hidden correction risks compared to industry averages within this highly competitive biopharmaceutical niche.